First Mercantile Trust’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.94M | Sell |
20,342
-1,345
| -6% | -$142K | 0.26% | 58 |
|
|
2021
Q2 | $2.7M | Sell |
21,687
-1,345
| -6% | -$161K | 0.32% | 47 |
|
|
2021
Q1 | $3.04M | Sell |
23,032
-1,108
| -5% | -$152K | 0.35% | 38 |
|
|
2020
Q4 | $3.2M | Buy |
24,140
+3,668
| +18% | +$444K | 0.36% | 39 |
|
|
2020
Q3 | $2.52M | Buy |
20,472
+1,181
| +6% | +$102K | 0.3% | 40 |
|
|
2020
Q2 | $1.68M | Buy |
19,291
+3,080
| +19% | +$246K | 0.21% | 60 |
|
|
2020
Q1 | $940K | Buy |
16,211
+2,535
| +19% | +$206K | 0.14% | 83 |
|
|
2019
Q4 | $1.26M | Sell |
13,676
-1,652
| -11% | -$145K | 0.15% | 75 |
|
|
2019
Q3 | $1.39M | Sell |
15,328
-3,366
| -18% | -$384K | 0.15% | 80 |
|
|
2019
Q2 | $2.21M | Sell |
18,694
-1,393
| -7% | -$140K | 0.23% | 50 |
|
|
2019
Q1 | $1.74M | Sell |
20,087
-6,363
| -24% | -$542K | 0.41% | 45 |
|
|
2018
Q4 | $1.67M | Sell |
26,450
-1,864
| -7% | -$128K | 0.4% | 50 |
|
|
2018
Q3 | $2.23M | Sell |
28,314
-1,452
| -5% | -$94.7K | 0.44% | 42 |
|
|
2018
Q2 | $1.78M | Buy |
29,766
+2,261
| +8% | +$122K | 0.36% | 58 |
|
|
2018
Q1 | $1.11M | Sell |
27,505
-4,212
| -13% | -$205K | 0.23% | 93 |
|
|
2017
Q4 | $1.67M | Sell |
31,717
-6,755
| -18% | -$361K | 0.33% | 65 |
|
|
2017
Q3 | $1.81M | Sell |
38,472
-2,860
| -7% | -$115K | 0.33% | 62 |
|
|
2017
Q2 | $1.46M | Sell |
41,332
-6,548
| -14% | -$202K | 0.26% | 78 |
|
|
2017
Q1 | $1.13M | Buy |
47,880
+5,080
| +12% | +$101K | 0.17% | 154 |
|
|
2016
Q4 | $572K | Sell |
42,800
-6,968
| -14% | -$112K | 0.09% | 301 |
|
|
2016
Q3 | $924K | Sell |
49,768
-5,632
| -10% | -$99.2K | 0.12% | 208 |
|
|
2016
Q2 | $679K | Hold |
55,400
| – | – | 0.08% | 327 |
|
|
2016
Q1 | $373K | Buy |
55,400
+7,600
| +16% | +$48.6K | 0.05% | 467 |
|
|
2015
Q4 | $441K | Sell |
47,800
-23,983
| -33% | -$223K | 0.05% | 480 |
|
|
2015
Q3 | $1.29M | Sell |
71,783
-5,455
| -7% | -$125K | 0.13% | 197 |
|
|
2015
Q2 | $2.3M | Buy |
77,238
+15,847
| +26% | +$398K | 0.2% | 126 |
|
|
2015
Q1 | $1.35M | Buy |
61,391
+14,765
| +32% | +$375K | 0.11% | 237 |
|
|
2014
Q4 | $1.28M | Buy |
46,626
+26,275
| +129% | +$639K | 0.11% | 255 |
|
|
2014
Q3 | $394K | Buy |
20,351
+8,637
| +74% | +$158K | 0.03% | 590 |
|
|
2014
Q2 | $199K | Buy |
11,714
+4,600
| +65% | +$63.3K | 0.02% | 719 |
|
|
2014
Q1 | $101K | Buy |
+7,114
| New | +$96.1K | 0.01% | 908 |
|
|
2013
Q4 | – | Sell |
-24,100
| Closed | -$285K | – | 1159 |
|
|
2013
Q3 | $285K | Buy |
+24,100
| New | +$309K | 0.02% | 687 |
|
Other funds holding EXAS
AIM
First Mercantile Trust's EXAS Position: Q3 2021 in Review
First Mercantile Trust reduced its Exact Sciences (EXAS) stake by 6.2% in Q3 2021, selling an estimated $142K and leaving 20,342 shares worth $1.94M. The position accounts for 0.26% of the portfolio, ranked #58.
First Mercantile Trust first reported a position in EXAS in Q3 2013 and has held it in 32 quarters since. The position peaked at $3.2M in Q4 2020. 601 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.
- First Mercantile Trust held 20,342 shares of Exact Sciences worth $1.94M as of Q3 2021.
- First Mercantile Trust sold 1,345 Exact Sciences shares in Q3 2021, an estimated $142K.
- Exact Sciences made up 0.26% of First Mercantile Trust's portfolio in Q3 2021, its #58 holding.
- First Mercantile Trust first reported a position in Exact Sciences in Q3 2013 and has held it in 32 quarters since.
- First Mercantile Trust's Exact Sciences position peaked at $3.2M in Q4 2020.
- 601 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.
Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.